Non-melanoma skin cancer

Actinic Keratoses: Evidence-Based Treatment Options
Actinic Keratoses
by Jacqueline McKesey, MD MS on
Dr. Hanke, a dermatologic surgeon who needs no introduction (but I’ll give one anyway!) provided us with an evidence-based discussion of field treatments available for actinic keratoses at ODAC 2021 conference. Just to name a few of Dr. Hanke’s accomplishments, he is the current Senior Vice President of the Skin Cancer Foundation, Senior editor of JDD, and the former president of the AAD, A …
JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer
JDD MARCH 2021 ISSUE
by NEXT STEPS IN DERM TEAM on
The March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, …
5-Fluorouracil Therapeutic Cheat Sheet
Fluoroplex
by Blair Allais, MD on
Actinic keratoses represent the most common dermatologic diagnosis in patients older than 45 years old in the United States and account for 5.2 million visits annually.1 Cutaneous field cancerization represents areas with a high burden of both clinical and subclinical actinic damage. Cryotherapy can often be combined with topical chemotherapy for a synergistic approach. We continue our series, The …
Ocular Dermoid in Patient With Basal Cell Nevus Syndrome
ocular dermoid
by NEXT STEPS IN DERM TEAM on
CASE A 47-year-old woman presented for Mohs Micrographic Surgery for a biopsy-proven basal cell carcinoma involving the right nasal ala. The patient had a history of basal cell nevus syndrome (BCNS) and previous history of multiple basal cell carcinomas. On initial examination, the patient was noted to have a few scattered pearly molluscoid papules on the head and neck, which were suspicio …
New and Emerging Therapies for Advanced Non-Melanoma Skin Cancer
Advanced Non-Melanoma Skin Cancer
by ANNA H. CHACON, MD on
At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference held January 17-20 in Orlando, FL, Dr. Desiree Ratner led a discussion on new and emerging therapies for advanced non-melanoma skin cancer. The session covered several treatments for patients including patidegib gel 2% and 4% applied once or twice daily in patients with basal cell carcinoma. Patidegib is a topical hedgehog in …